The proximal origin of SARS-CoV-2.
Nat Med. 2020; 26: 450-452
COVID-19 coronavirus pandemic.
COVID-19 dashboard by the Heart for Programs Science and Engineering (CSS) at Johns Hopkins College (JHU).
Persistent signs in sufferers after acute COVID-19.
JAMA. 2020; 324: 603-605
Neurologic options in extreme SARS-CoV-2 an infection.
N Engl J Med. 2020; 382: 2268-2270
Long run respiratory problems of covid-19.
BMJ. 2020; 370m3001
Studying from a retraction.
Lancet. 2020; 3961056
Misinformation in the course of the coronavirus illness 2019 outbreak: how information emerges from noise.
Crit Care Explor. 2020; 2e0098
The Dialog: Coronavirus analysis carried out too quick is testing publishing safeguards, unhealthy science is getting by.
Scientists lower peer-review corners below stress of COVID-19 pandemic.
SARS-CoV-2/COVID-19: evolving actuality, world response, information gaps, and alternatives.
Shock. 2020; 54: 416-437
Regularly requested questions on SARS.
Center East respiratory syndrome coronavirus (MERS-CoV) – The Kingdom of Saudi Arabia.
Structural foundation for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
Science. 2020; 369: 1249-1255
Evasion of sort I interferon by SARS-CoV-2.
Cell Rep. 2020; 33108234
Mechanisms of SARS-CoV-2 transmission and pathogenesis.
Developments Immunol. 2020; 41: 1100-1115
Detection of SARS-CoV-2 in several types of scientific specimens.
JAMA. 2020; 323: 1843-1844
Proof for gastrointestinal an infection of SARS-CoV-2.
Gastroenterology. 2020; 158: 1831-1833.e3
Essential function of sort III interferon in controlling SARS-CoV-2 an infection in human intestinal epithelial cells.
Cell Rep. 2020; 32107863
Productive replication of Center East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response.
Virology. 2014; 454–455: 197-205
Cytokine responses in extreme acute respiratory syndrome coronavirus-infected macrophages in vitro: potential relevance to pathogenesis.
J Virol. 2005; 79: 7819-7826
Lively replication of Center East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis.
J Infect Dis. 2014; 209: 1331-1342
The novel extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) straight decimates human spleens and lymph nodes.
medRxiv. 2020; ()
Alveolar macrophage dysfunction and cytokine storm within the pathogenesis of two extreme COVID-19 sufferers.
EBioMedicine. 2020; 57102833
Virological evaluation of hospitalized sufferers with COVID-2019.
Nature. 2020; 581: 465-469
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate mannequin.
Science. 2020; 368: 1012-1015
Medical development and viral load in a neighborhood outbreak of coronavirus-associated SARS pneumonia: a potential examine.
Lancet. 2003; 361: 1767-1772
Viral load of SARS-CoV-2 in scientific samples.
Lancet Infect Dis. 2020; 20: 411-412
Temporal dynamics in viral shedding and transmissibility of COVID-19.
Nat Med. 2020; 26: 672-675
Viral shedding and antibody response in 37 sufferers with Center East respiratory syndrome coronavirus an infection.
Clin Infect Dis. 2016; 62: 477-483
Higher respiratory tract ranges of SARS-CoV-2 RNA and period of viral RNA shedding don’t differ between sufferers with gentle and extreme/vital COVID-19.
J Infect Dis. 2021; 223: 15-18
SARS-CoV-2 an infection protects towards rechallenge in rhesus macaques.
Science. 2020; 369: 812-817
Detection of SARS-CoV-2-specific humoral and mobile immunity in COVID-19 convalescent people.
Immunity. 2020; 52: 971-977.e3
Antibody response utilizing six completely different serological assays in a totally PCR-tested neighborhood after a COVID-19 outbreak—the CoNAN examine.
Clin Microbiol Infect. 2021; 27: 470.e1-470.e9
Strong T cell immunity in convalescent people with asymptomatic or gentle COVID-19.
Cell. 2020; 183: 158-168.e14
Fast decay of anti-SARS-CoV-2 antibodies in individuals with gentle Covid-19.
N Engl J Med. 2020; 383: 1085-1087
Disappearance of antibodies to SARS-associated coronavirus after restoration.
N Engl J Med. 2007; 357: 1162-1163
Lack of peripheral reminiscence B cell responses in recovered sufferers with extreme acute respiratory syndrome: a six-year follow-up examine.
J Immunol. 2011; 186: 7264-7268
Period of antibody responses after extreme acute respiratory syndrome.
Emerg Infect Dis. 2007; 13: 1562-1564
Lengthy-term persistence of IgG antibodies in SARS-CoV contaminated healthcare staff.
medRxiv. 2020; ()
Immunological reminiscence to SARS-CoV-2 assessed for as much as 8 months after an infection.
Science. 2021; 371eabf4063
SARS-CoV-2-specific T cell immunity in instances of COVID-19 and SARS, and uninfected controls.
Nature. 2020; 584: 457-462
SARS-CoV-2 T cell immunity: specificity, perform, sturdiness, and function in safety.
Sci Immunol. 2020; 5eabd6160
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed people.
Science. 2020; 370: 89-94
Antibodies induced by receptor-binding area in spike protein of SARS-CoV don’t cross-neutralize the novel human coronavirus hCoV-EMC.
J Infect. 2013; 67: 348-350
Antigenic cross-reactivity between extreme acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43.
J Infect Dis. 2005; 191: 2033-2037
Serological responses in sufferers with extreme acute respiratory syndrome coronavirus an infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63.
Clin Diagn Lab Immunol. 2005; 12: 1317-1321
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections.
Cell Rep. 2020; 31107725
The receptor binding area of the viral spike protein is an immunodominant and extremely particular goal of antibodies in SARS-CoV-2 sufferers.
Sci Immunol. 2020; 5eabc8413
vWei P-F, ed. Analysis and remedy protocol for novel coronavirus pneumonia (trial model 7). Chin Med J (Engl) 2020; 133: 1087–95.
The epidemiological traits of an outbreak of 2019 novel coronavirus illnesses (COVID-19) in China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145-151
SARS-CoV-2 reverse genetics reveals a variable an infection gradient within the respiratory tract.
Cell. 2020; 182: 429-446.e14
Comparability of hospitalized sufferers with ARDS brought on by COVID-19 and H1N1.
Chest. 2020; 158: 195-205
Genomewide affiliation examine of extreme Covid-19 with respiratory failure.
N Engl J Med. 2020; 383: 1522-1534
Potential silent hypoxemia in a COVID-19 affected person: a case report.
Ann Med Surg (Lond). 2020; 60: 583-586
The pathophysiology of ‘joyful’ hypoxemia in COVID-19.
Respir Res. 2020; 21: 198
Medical traits of coronavirus illness 2019 in China.
N Engl J Med. 2020; 382: 1708-1720
Pathophysiology of dyspnea.
N Engl J Med. 1995; 333: 1547-1553
Measuring the ventilatory response to hypoxia.
J Physiol. 2007; 584: 285-293
Mechanical air flow to attenuate development of lung harm in acute respiratory failure.
Am J Respir Crit Care Med. 2017; 195: 438-442
Why COVID-19 silent hypoxemia is baffling to physicians.
Am J Respir Crit Care Med. 2020; 202: 356-360
Irregular pulmonary perform in COVID-19 sufferers at time of hospital discharge.
Eur Respir J. 2020; 552001217
Hypoxaemia associated to COVID-19: vascular and perfusion abnormalities on dual-energy CT.
Lancet Infect Dis. 2020; 20: 1365-1366
SARS-CoV-2 viral load predicts mortality in sufferers with and with out most cancers who’re hospitalized with COVID-19.
Most cancers Cell. 2020; 38: 661-671.e2
Influence of SARS-CoV-2 viral load on threat of intubation and mortality amongst hospitalized sufferers with coronavirus illness 2019.
Clin Infect Dis. 2020; ()
The protein expression profile of ACE2 in human tissues.
Mol Syst Biol. 2020; 16e9610
SARS-CoV-2 cell entry relies on ACE2 and TMPRSS2 and is blocked by a clinically confirmed protease inhibitor.
Cell. 2020; 181: 271-280.e8
The microbiome and the respiratory tract.
Annu Rev Physiol. 2016; 78: 481-504
Airborne transmission of SARS-CoV-2: the world ought to face the truth.
Environ Int. 2020; 139105730
Airborne transmission of extreme acute respiratory syndrome coronavirus-2 to healthcare staff: a story assessment.
Anaesthesia. 2020; 75: 1086-1095
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
Science. 2020; 370: 856-860
AXL is a candidate receptor for SARS-CoV-2 that promotes an infection of pulmonary and bronchial epithelial cells.
Cell Res. 2021; 31: 126-140
Pulmonary autopsy findings in a sequence of COVID-19 instances from northern Italy: a two-centre descriptive examine.
Lancet Infect Dis. 2020; 20: 1135-1140
Presence of hyaluronan in lung alveoli in extreme Covid-19: a gap for brand new remedy choices?.
J Biol Chem. 2020; 295: 15418-15422
Pathological proof for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge affected person.
Cell Res. 2020; 30: 541-543
Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19.
N Engl J Med. 2020; 383: 120-128
SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis.
Am J Clin Pathol. 2020; 154: 466-474
Lung pathology of deadly extreme acute respiratory syndrome.
Lancet. 2003; 361: 1773-1778
The Italian coronavirus illness 2019 outbreak: suggestions from scientific observe.
Anaesthesia. 2020; 75: 724-732
COVID-19 pneumonia: completely different respiratory therapies for various phenotypes?.
Intensive Care Med. 2020; 46: 1099-1102
Warning about early intubation and mechanical air flow in COVID-19.
Ann Intensive Care. 2020; 10: 78
Pathophysiology of COVID-19-associated acute respiratory misery syndrome: a multicentre potential observational examine.
Lancet Respir Med. 2020; 8: 1201-1208
The respiratory drive: an neglected tile of COVID-19 pathophysiology.
Am J Respir Crit Care Med. 2020; 202: 1079-1080
Pulmonary fibrosis: pathogenesis, etiology and regulation.
Mucosal Immunol. 2009; 2: 103-121
Pressing avenues within the remedy of COVID-19: focusing on downstream irritation to stop catastrophic syndrome.
Joint Bone Backbone. 2020; 87: 191-193
A possible remedy of COVID-19 with TGF-β blockade.
Int J Biol Sci. 2020; 16: 1954-1955
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?.
Eur Respir J. 2020; 562003167
Pathology and pathogenesis of extreme acute respiratory syndrome.
Am J Pathol. 2007; 170: 1136-1147
Influence of extreme acute respiratory syndrome (SARS) on pulmonary perform, useful capability and high quality of life in a cohort of survivors.
Thorax. 2005; 60: 401-409
Purposeful incapacity 5 years after acute respiratory misery syndrome.
N Engl J Med. 2011; 364: 1293-1304
Pulmonary pathology of extreme acute respiratory syndrome in Toronto.
Mod Pathol. 2005; 18: 1-10
Pathogenetic mechanisms of extreme acute respiratory syndrome.
Virus Res. 2008; 133: 4-12
Dying with SARS-CoV-2 infection-an post-mortem examine of the primary consecutive 80 instances in Hamburg, Germany.
Int J Authorized Med. 2020; 134: 1275-1284
COVID-19 autopsies, Oklahoma, USA.
Am J Clin Pathol. 2020; 153: 725-733
CT in coronavirus illness 2019 (COVID-19): a scientific assessment of chest CT findings in 4410 grownup sufferers.
Eur Radiol. 2020; 30: 6129-6138
Prediction of the event of pulmonary fibrosis utilizing serial thin-section CT and scientific options in sufferers discharged after remedy for COVID-19 pneumonia.
Korean J Radiol. 2020; 21: 746-755
Incidence of thrombotic problems in critically ailing ICU sufferers with COVID-19.
Thromb Res. 2020; 191: 145-147
Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in extreme acute respiratory syndrome coronavirus 2 an infection.
J Vasc Surg Venous Lymphat Disord. 2021; 9: 23-35
Validation of the Caprini venous thromboembolism threat evaluation mannequin in critically ailing surgical sufferers.
JAMA Surg. 2015; 150: 941-948
Greater prevalence of pulmonary macrothrombi in SARS-CoV-2 than in influenza A: post-mortem outcomes from ‘Spanish flu’ 1918/1919 in Switzerland to Coronavirus illness 2019.
J Pathol Clin Res. 2021; 7: 135-143
Threat elements related to acute respiratory misery syndrome and dying in sufferers with coronavirus illness 2019 pneumonia in Wuhan, China.
JAMA Intern Med. 2020; 180: 934-943
Medical course and threat elements for mortality of grownup inpatients with COVID-19 in Wuhan, China: a retrospective cohort examine.
Lancet. 2020; 395: 1054-1062
Medical traits of 113 deceased sufferers with coronavirus illness 2019: retrospective examine.
BMJ. 2020; 368m1091
Medical traits of Covid-19 in New York Metropolis.
N Engl J Med. 2020; 382: 2372-2374
ISTH interim steerage on recognition and administration of coagulopathy in COVID-19.
J Thromb Haemost. 2020; 18: 1023-1026
Cytokine elevation in extreme and important COVID-19: a speedy systematic assessment, meta-analysis, and comparability with different inflammatory syndromes.
Lancet Respir Med. 2020; 8: 1233-1244
Laboratory abnormalities in sufferers with COVID-2019 an infection.
Clin Chem Lab Med. 2020; 58: 1131-1134
Myocardial harm in extreme COVID-19 is just like pneumonias of different origin: outcomes from a multicentre examine.
ESC Coronary heart Fail. 2021; 8: 37-46
Impaired immune cell cytotoxicity in extreme COVID-19 is IL-6 dependent.
J Clin Make investments. 2020; 130: 4694-4703
Endothelial cell an infection and endotheliitis in COVID-19.
Lancet. 2020; 395: 1417-1418
The evolution of pulmonary pathology in deadly COVID-19 illness: an post-mortem examine with scientific correlation.
Virchows Arch. 2020; 477: 349-357
In situ detection of SARS-CoV-2 in lungs and airways of sufferers with COVID-19.
Mod Pathol. 2020; 33: 2104-2114
Renal histopathological evaluation of 26 postmortem findings of sufferers with COVID-19 in China.
Kidney Int. 2020; 98: 219-227
The rising spectrum of cardiopulmonary pathology of the coronavirus illness 2019 (COVID-19): report of three autopsies from Houston, Texas, and assessment of post-mortem findings from different United States cities.
Cardiovasc Pathol. 2020; 48107233
Diffuse alveolar harm and thrombotic microangiopathy are the primary histopathological findings in lung tissue biopsy samples of COVID-19 sufferers.
Pathol Res Pract. 2020; 216153228
The distinctive traits of COVID-19 coagulopathy.
Crit Care. 2020; 24: 360
Time to contemplate histologic sample of lung harm to deal with critically ailing sufferers with COVID-19 an infection.
Intensive Care Med. 2020; 46: 1124-1126
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia.
Lancet Rheumatol. 2020; 2: e437-e445
Thrombolysis restores perfusion in COVID-19 hypoxia.
Br J Haematol. 2020; 190: e270-e274
Coagulopathy and antiphospholipid antibodies in sufferers with Covid-19.
N Engl J Med. 2020; 382: e38
Medical traits of 138 hospitalized sufferers with 2019 novel coronavirus-infected pneumonia in Wuhan, China.
JAMA. 2020; 323: 1061-1069
Air flow administration and scientific outcomes in invasively ventilated sufferers with COVID-19 (PRoVENT-COVID): a nationwide, multicentre, observational cohort examine.
Lancet Respir Med. 2021; 9: 139-148
Prevalence of phenotypes of acute respiratory misery syndrome in critically ailing sufferers with COVID-19: a potential observational examine.
Lancet Respir Med. 2020; 8: 1209-1218
Multiorgan and renal tropism of SARS-CoV-2.
N Engl J Med. 2020; 383: 590-592
Post-mortem findings and venous thromboembolism in sufferers with COVID-19: a potential cohort examine.
Ann Intern Med. 2020; 173: 268-277
Transcriptional profiling of leukocytes in critically ailing COVID19 sufferers: implications for interferon response and coagulation.
Intensive Care Med Exp. 2020; 8: 75
Early postmortem mapping of SARS-CoV-2 RNA in sufferers with COVID-19 and the correlation with tissue harm.
Elife. 2021; 10e60361
COVID-19, ACE2, and the cardiovascular penalties.
Am J Physiol Coronary heart Circ Physiol. 2020; 318: H1084-H1090
Mechanisms and remedy of organ failure in sepsis.
Nat Rev Nephrol. 2018; 14: 417-427
Extrapulmonary manifestations of COVID-19.
Nat Med. 2020; 26: 1017-1032
Toll-like receptors and COVID-19: a two-faced story with an thrilling ending.
Future Sci OA. 2020; 6FSO605
Toll-like receptor 3 signaling by way of TRIF contributes to a protecting innate immune response to extreme acute respiratory syndrome coronavirus an infection.
MBio. 2015; 6: e00638-e00715
Presence of genetic variants amongst younger males with extreme COVID-19.
JAMA. 2020; 324: 663-673
Inborn errors of sort I IFN immunity in sufferers with life-threatening COVID-19.
Science. 2020; 370eabd4570
Pathological irritation in sufferers with COVID-19: a key function for monocytes and macrophages.
Nat Rev Immunol. 2020; 20: 355-362
Medical options of sufferers contaminated with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020; 395: 497-506
Viral RNA load in plasma is related to vital sickness and a dysregulated host response in COVID-19.
Crit Care. 2020; 24: 691
Is a “cytokine storm” related to COVID-19?.
JAMA Intern Med. 2020; 180: 1152-1154
Detectable serum extreme acute respiratory syndrome coronavirus 2 viral load (RNAemia) is intently correlated with drastically elevated interleukin 6 stage in critically ailing sufferers with coronavirus illness 2019.
Clin Infect Dis. 2020; 71: 1937-1942
Immune cell profiling of COVID-19 sufferers within the restoration stage by single-cell sequencing.
Cell Discov. 2020; 6: 31
Diagnostic utility of scientific laboratory knowledge determinations for sufferers with the extreme COVID-19.
J Med Virol. 2020; 92: 791-796
Medical predictors of mortality resulting from COVID-19 based mostly on an evaluation of knowledge of 150 sufferers from Wuhan, China.
Intensive Care Med. 2020; 46: 846-848
Distinctive inflammatory profile is related to greater SARS-CoV-2 acute respiratory misery syndrome (ARDS) mortality.
Am J Physiol Regul Integr Comp Physiol. 2021; 320: R250-R257
Medical and immunologic options in extreme and reasonable coronavirus illness 2019.
J Clin Make investments. 2020; 130: 2620-2629
Immune cell profiling of COVID-19 sufferers within the restoration stage by single-cell sequencing.
Cell Discov. 2020; 6: 31
A longitudinal examine of immune cells in extreme COVID-19 sufferers.
Entrance Immunol. 2020; 11580250
Complicated immune dysregulation in COVID-19 sufferers with extreme respiratory failure.
Cell Host Microbe. 2020; 27: 992-1000.e3
Peripheral immunophenotypes in kids with multisystem inflammatory syndrome related to SARS-CoV-2 an infection.
Nat Med. 2020; 26: 1701-1707
Multisystem inflammatory syndrome in U.S. kids and adolescents.
N Engl J Med. 2020; 383: 334-346
Multisystem inflammatory syndrome in kids in New York State.
N Engl J Med. 2020; 383: 347-358
Autoantibodies towards sort I IFNs in sufferers with life-threatening COVID-19.
Science. 2020; 370eabd4585
Impaired sort I interferon exercise and inflammatory responses in extreme COVID-19 sufferers.
Science. 2020; 369: 718-724
Imbalanced host response to SARS-CoV-2 drives growth of COVID-19.
Cell. 2020; 181: 1036-1045.e9
Sort I IFN immunoprofiling in COVID-19 sufferers.
J Allergy Clin Immunol. 2020; 146: 206-208.e2
Untuned antiviral immunity in COVID-19 revealed by temporal sort I/III interferon patterns and flu comparability.
Nat Immunol. 2021; 22: 32-40
Immunophenotyping of COVID-19 and influenza highlights the function of sort I interferons in growth of extreme COVID-19.
Sci Immunol. 2020; 5eabd1554
Cytokine ranges in critically ailing sufferers with COVID-19 and different situations.
JAMA. 2020; 324: 1565-1567
COVID-19: What sort of cytokine storm are we coping with?.
J Med Virol. 2021; 93: 197-198
Heightened innate immune responses within the respiratory tract of COVID-19 sufferers.
Cell Host Microbe. 2020; 27: 883-890.e2
Transcriptomic traits of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 sufferers.
Emerg Microbes Infect. 2020; 9: 761-770
Compartmental immunophenotyping in COVID-19 ARDS: a case sequence.
J Allergy Clin Immunol. 2021; 147: 81-91
Affiliation of COVID-19 irritation with activation of the C5a-C5aR1 axis.
Nature. 2020; 588: 146-150
A human pluripotent stem cell-based platform to review SARS-CoV-2 tropism and mannequin virus an infection in human cells and organoids.
Cell Stem Cell. 2020; 27: 125-136.e7
Two distinct immunopathological profiles in post-mortem lungs of COVID-19.
Nat Commun. 2020; 115086
Inflammasome formation within the lungs of sufferers with deadly COVID-19.
Inflamm Res. 2021; 70: 7-10
Expression of the SARS-CoV-2 cell receptor gene ACE2 in all kinds of human tissues.
Infect Dis Poverty. 2020; 9: 45
Hyperferritinemia in critically ailing sufferers.
Crit Care Med. 2020; 48: 459-465
Macrophage activation-like syndrome: an immunological entity related to speedy development to dying in sepsis.
BMC Med. 2017; 15: 172
Predictors of in-hospital COVID-19 mortality: a complete systematic assessment and meta-analysis exploring variations by age, intercourse and well being situations.
PLoS One. 2020; 15e0241742
Ferritin within the coronavirus illness 2019 (COVID-19): a scientific assessment and meta-analysis.
J Clin Lab Anal. 2020; 34e23618
Excessive mortality in COVID-19 sufferers with gentle respiratory illness.
Eur J Clin Make investments. 2020; 50e13314
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 an infection.
Blood. 2020; 136: 489-500
Anakinra for extreme types of COVID-19: a cohort examine.
Lancet Rheumatol. 2020; 2: e393-e400
Interleukin-1 blockade with high-dose anakinra in sufferers with COVID-19, acute respiratory misery syndrome, and hyperinflammation: a retrospective cohort examine.
Lancet Rheumatol. 2020; 2: e325-e331
Favorable anakinra responses in extreme covid-19 sufferers with secondary hemophagocytic lymphohistiocytosis.
Cell Host Microbe. 2020; 28: 117-123.e1
A assessment of the primary histopathological findings in coronavirus illness 2019.
Hum Pathol. 2020; 105: 74-83
Improvement and validation of the HScore, a rating for the analysis of reactive hemophagocytic syndrome.
Arthritis Rheumatol. 2014; 66: 2613-2620
Immune-inflammatory parameters in COVID-19 instances: a scientific assessment and meta-analysis.
Entrance Med (Lausanne). 2020; 7: 301
COVID-19 sufferers exhibit much less pronounced immune suppression in contrast with bacterial septic shock sufferers.
Crit Care. 2020; 24: 263
Complement activation in sufferers with COVID-19: a novel therapeutic goal.
J Allergy Clin Immunol. 2020; 146: 215-217
Systemic complement activation is related to respiratory failure in COVID-19 hospitalized sufferers.
Proc Natl Acad Sci USA. 2020; 117: 25018-25025
Procalcitonin for analysis of an infection and information to antibiotic choices: previous, current and future.
BMC Med. 2011; 9: 107
Assessment of scientific observe pointers on the usage of procalcitonin in infections.
Infect Dis (Lond). 2020; 52: 227-234
Comparative evaluation of laboratory indexes of extreme and non-severe sufferers contaminated with COVID-19.
Clin Chim Acta. 2020; 509: 180-194
Essential laboratory parameters in COVID-19 analysis and prognosis: an up to date meta-analysis.
Med Clin (Barc). 2020; 155: 143-151
Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 instances?.
Crit Care. 2020; 24: 600
Medical course and outcomes of critically ailing sufferers with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational examine.
Lancet Respir Med. 2020; 8: 475-481
COVID-19 in folks with diabetes: understanding the explanations for worse outcomes.
Lancet Diabetes Endocrinol. 2020; 8: 782-792
Plasma glucose ranges and diabetes are impartial predictors for mortality and morbidity in sufferers with SARS.
Diabet Med. 2006; 23: 623-628
Expression profile of SARS-CoV-2 host receptors in human pancreatic islets revealed upregulation of ACE2 in diabetic donors.
Biology (Basel). 2020; 9: E215
COVID-19 and the endocrine system: exploring the unexplored.
J Endocrinol Make investments. 2020; 43: 1027-1031
Affiliation of blood glucose management and outcomes in sufferers with COVID-19 and pre-existing sort 2 diabetes.
Cell Metab. 2020; 31: 1068-1077.e3
Exploring illnesses/traits and blood proteins causally associated to expression of ACE2, the putative receptor of SARS-CoV-2: a mendelian randomization evaluation highlights tentative relevance of diabetes-related traits.
Diabetes Care. 2020; 43: 1416-1426
Glycemic variability in diabetes will increase the severity of influenza.
MBio. 2020; 11: e02841-e02849
Diabetes exacerbates an infection by way of hyperinflammation by signaling by TLR4 and RAGE.
MBio. 2017; 8: e00818-e00917
COVID-19, diabetes mellitus and ACE2: the conundrum.
Diabetes Res Clin Pract. 2020; 162108132
COVID-19 and the RAAS-a potential function for angiotensin II?.
Crit Care. 2020; 24: 136
Affiliation of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 analysis and mortality.
JAMA. 2020; 324: 168-177
Angiotensin II induces interleukin-6 transcription in vascular clean muscle cells by pleiotropic activation of nuclear factor-kappa B transcription elements.
Circ Res. 1999; 84: 695-703
SARS-CoV-2 as an element to disbalance the renin-angiotensin system: a suspect within the case of exacerbated IL-6 manufacturing.
J Immunol. 2020; 205: 1198-1206
The pivotal hyperlink between ACE2 deficiency and SARS-CoV-2 an infection.
Eur J Intern Med. 2020; 76: 14-20
Influence of intercourse and gender on COVID-19 outcomes in Europe.
Biol Intercourse Differ. 2020; 11: 29
Androgen-deprivation therapies for prostate most cancers and threat of an infection by SARS-CoV-2: a population-based examine (N = 4532).
Ann Oncol. 2020; 31: 1040-1045
Contemplating how organic intercourse impacts immune responses and COVID-19 outcomes.
Nat Rev Immunol. 2020; 20: 442-447
Dysregulation of immune response in sufferers with Coronavirus 2019 (COVID-19) in Wuhan, China.
Clin Infect Dis. 2020; 71: 762-768
Neutrophil-to-lymphocyte ratio as a predictive biomarker for moderate-severe ARDS in extreme COVID-19 sufferers.
Crit Care. 2020; 24: 288
Entire blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for extreme COVID-19.
Nat Commun. 2020; 115243
Complete mapping of immune perturbations related to extreme COVID-19.
Sci Immunol. 2020; 5eabd7114
An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19.
Clin Infect Dis. 2020; 71: 2272-2275
Elevated calprotectin and irregular myeloid cell subsets discriminate extreme from gentle COVID-19.
Cell. 2020; 182: 1401-1418.e18
Extreme COVID-19 is marked by a dysregulated myeloid cell compartment.
Cell. 2020; 182: 1419-1440.e23
Growth of myeloid-derived suppressor cells in sufferers with extreme coronavirus illness (COVID-19).
Cell Loss of life Differ. 2020; 27: 3196-3207
Myeloid-derived suppressor cells evolve throughout sepsis and may improve or attenuate the systemic inflammatory response.
Infect Immun. 2012; 80: 2026-2034
A single-cell atlas of the peripheral immune response in sufferers with extreme COVID-19.
Nat Med. 2020; 26: 1070-1076
Cytokine storm and leukocyte modifications in gentle versus extreme SARS-CoV-2 an infection: assessment of 3939 COVID-19 sufferers in China and rising pathogenesis and remedy ideas.
J Leukoc Biol. 2020; 108: 17-41
Neutrophil extracellular traps in COVID-19.
JCI Perception. 2020; 5e138999
Focusing on potential drivers of COVID-19: Neutrophil extracellular traps.
J Exp Med. 2020; 217e20200652
Immunophenotyping of circulating leukocytes reveal non-specific activation of innate and adaptive immune methods in multi-system inflammatory syndrome of childhood temporally related to SARS-Cov-2 an infection: descriptive cohort examine.
Preprints. 2020; ()
A longitudinal examine of immune cells in extreme COVID-19 sufferers.
Entrance Immunol. 2020; 11580250
A dynamic COVID-19 immune signature contains associations with poor prognosis.
Nat Med. 2020; 26: 1623-1635
Pathogenic T cells and inflammatory monocytes incite inflammatory storm in extreme COVID-19 sufferers.
Natl Sci Rev. 2020; 7: 998-1002
Single-cell panorama of bronchoalveolar immune cells in sufferers with COVID-19.
Nat Med. 2020; 26: 842-844
COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes.
J Clin Make investments. 2020; 130: 6290-6300
Circuits between contaminated macrophages and T cells in SARS-CoV-2 pneumonia.
Nature. 2021; 590: 635-641
Monocytic HLA-DR expression kinetics in septic shock sufferers with completely different pathogens, websites of an infection and opposed outcomes.
Crit Care. 2020; 24: 110
Put up-operative immune suppression is mediated by way of reversible, Interleukin-10 dependent pathways in circulating monocytes following main belly surgical procedure.
PLoS One. 2018; 13e0203795
Lack of restoration in monocyte human leukocyte antigen-DR expression is independently related to the event of sepsis after main trauma.
Crit Care. 2010; 14: R208
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.
Intensive Care Med. 2006; 32: 1175-1183
Differential down-regulation of HLA-DR on monocyte subpopulations throughout systemic irritation.
Crit Care. 2010; 14: R61
Affect of surgical intervention within the immune response of severely injured sufferers.
Intensive Care Med. 2004; 30: 96-102
Lowered monocytic human leukocyte antigen-DR expression signifies immunosuppression in critically ailing COVID-19 sufferers.
Anesth Analg. 2020; 131: 993-999
Systemically evaluating host immunity between survived and deceased COVID-19 sufferers.
Cell Mol Immunol. 2020; 17: 875-877
Extreme COVID-19 is related to deep and sustained multifaceted mobile immunosuppression.
Intensive Care Med. 2020; 46: 1769-1771
Coronavirus illness 2019 as a specific sepsis: a 2-week follow-up of normal immunological parameters in critically ailing sufferers.
Intensive Care Med. 2020; 46: 1764-1765
Huge enhance in monocyte HLA-DR expression can be utilized to discriminate between septic shock and hemophagocytic lymphohistiocytosis-induced shock.
Crit Care. 2018; 22: 213
Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol throughout septic shock.
Am J Respir Crit Care Med. 2004; 169: 1144-1151
The CD8 T cell response to respiratory virus infections.
Entrance Immunol. 2018; 9: 678
Decreased T cell populations contribute to the elevated severity of COVID-19.
Clin Chim Acta. 2020; 508: 110-114
As plain because the nostril in your face: the case for a nasal (mucosal) route of vaccine administration for Covid-19 illness prevention.
Entrance Immunol. 2020; 11591897
Longitudinal hematologic and immunologic variations related to the development of COVID-19 sufferers in China.
J Allergy Clin Immunol. 2020; 146: 89-100
T-cell subset counts in peripheral blood can be utilized as discriminatory biomarkers for analysis and severity prediction of coronavirus illness 2019.
J Infect Dis. 2020; 222: 198-202
Medical and immune options of hospitalized pediatric sufferers with coronavirus illness 2019 (COVID-19) in Wuhan, China.
JAMA Netw Open. 2020; 3e2010895
Marked T cell activation, senescence, exhaustion and skewing in direction of TH17 in sufferers with COVID-19 pneumonia.
Nat Commun. 2020; 113434
Traits of peripheral lymphocyte subset alteration in COVID-19 pneumonia.
J Infect Dis. 2020; 221: 1762-1769
The inhibition of IL-2/IL-2R offers rise to CD8+ T cell and lymphocyte lower by JAK1-STAT5 in vital sufferers with COVID-19 pneumonia.
Cell Loss of life Dis. 2020; 11: 429
Utilizing IL-2R/lymphocytes for predicting the scientific development of sufferers with COVID-19.
Clin Exp Immunol. 2020; 201: 76-84
IL-6 and CD8+ T cell counts mixed are an early predictor of in-hospital mortality of sufferers with COVID-19.
JCI Perception. 2020; 5e139024
Selective CD8 cell discount by SARS-CoV-2 is related to a worse prognosis and systemic irritation in COVID-19 sufferers.
Clin Immunol. 2020; 217108486
Longitudinal traits of lymphocyte responses and cytokine profiles within the peripheral blood of SARS-CoV-2 contaminated sufferers.
EBioMedicine. 2020; 55102763
The laboratory checks and host immunity of COVID-19 sufferers with completely different severity of sickness.
JCI Perception. 2020; 5e137799
Extreme immunosuppression and never a cytokine storm characterizes COVID-19 infections.
JCI Perception. 2020; 5e140329
SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in sufferers hospitalized with coronavirus illness 2019.
J Med Virol. 2021; 93: 375-382
Targets of T cell responses to SARS-CoV-2 coronavirus in people with COVID-19 illness and unexposed people.
Cell. 2020; 181: 1489-1501.e15
Postmortem examination of sufferers with COVID-19.
JAMA. 2020; 323: 2518-2520
SARS-CoV-2 viral load is related to elevated illness severity and mortality.
Nat Commun. 2020; 115493
Relationship between SARS-CoV-2 an infection and the incidence of ventilator-associated decrease respiratory tract infections: a European multicenter cohort examine.
Intensive Care Med. 2021; 47: 188-198
Influenza A virus an infection induces hyperresponsiveness in human lung tissue-resident and peripheral blood NK cells.
Entrance Immunol. 2019; 101116
Rising insights into pure killer cells in human peripheral tissues.
Nat Rev Immunol. 2016; 16: 310-320
COVID-19 pneumonia: CD8+ T and NK cells are decreased in quantity however compensatory elevated in cytotoxic potential.
Clin Immunol. 2020; 218108516
Human lung pure killer cells are predominantly comprised of extremely differentiated hypofunctional CD69−CD56dim cells.
J Allergy Clin Immunol. 2017; 139: 1321-1330.e4
Pure killer cell immunotypes associated to COVID-19 illness severity.
Sci Immunol. 2020; 5eabd6832
Human B cell clonal growth and convergent antibody responses to SARS-CoV-2.
Cell Host Microbe. 2020; 28 (): 516
Deep sequencing of B cell receptor repertoires from COVID-19 sufferers reveals robust convergent immune signatures.
Entrance Immunol. 2020; 11605170
Convergent antibody responses to SARS-CoV-2 in convalescent people.
Nature. 2020; 584: 437-442
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies.
Proc Natl Acad Sci USA. 2007; 104: 12123-12128
Identification of an antigenic determinant on the S2 area of the extreme acute respiratory syndrome coronavirus spike glycoprotein able to inducing neutralizing antibodies.
J Virol. 2004; 78: 6938-6945
Potent neutralizing antibodies towards SARS-CoV-2 recognized by high-throughput single-cell sequencing of convalescent sufferers’ B cells.
Cell. 2020; 182: 73-84.e16
Human neutralizing antibodies elicited by SARS-CoV-2 an infection.
Nature. 2020; 584: 115-119
A potential function for B cells in COVID-19? Lesson from sufferers with agammaglobulinemia.
J Allergy Clin Immunol. 2020; 146: 211-213.e4
Two X-linked agammaglobulinemia sufferers develop pneumonia as COVID-19 manifestation however get well.
Pediatr Allergy Immunol. 2020; 31: 565-569
Anti-CD20 and COVID-19 in a number of sclerosis and associated problems: a case sequence of 60 sufferers from Madrid, Spain.
Mult Scler Relat Disord. 2020; 42102185
Anti-CD20 immunosuppressive disease-modifying therapies and COVID-19.
Mult Scler Relat Disord. 2020; 41102135
The BTK inhibitor ibrutinib could shield towards pulmonary harm in COVID-19-infected sufferers.
Blood. 2020; 135: 1912-1915
In protection of evidence-based drugs for the remedy of COVID-19 acute respiratory misery syndrome.
Ann Am Thorac Soc. 2020; 17: 787-789